Outpatient treatment of febrile episodes in low‐risk neutropenic patients with cancer

Cancer

Volumn 71, Issue 11, 1993, Pages 3640-3646

  Rubenstein, Edward B ^a   Rolston, Kenneth ^a   Escalante, Carmen ^a   Manzullo, Ellen ^a   Hughes, Pamela ^a   Fender, Andrew ^a   Elting, Linda ^a   Bodey, Gerald P ^a   Holmes, Frankie ^a   Loewy, John ^a   Moreland, Betty ^b   Kennedy, Kathryn ^a   Benjamin, Robert S ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c M D Anderson Cancer Center ^*

Author keywords

cancer; fever; neutropenia; outpatient antibiotic therapy

Indexed keywords

AZTREONAM; CIPROFLOXACIN; CISPLATIN; CLINDAMYCIN; INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER PATIENT; CANDIDIASIS; COLITIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; STAPHYLOCOCCUS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AMBULATORY CARE; AZTREONAM; BACTEREMIA; BACTERIAL INFECTIONS; CIPROFLOXACIN; CLINDAMYCIN; FEMALE; FEVER; HUMAN; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGE; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 0027300930     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930601)71:11<3640::AID-CNCR2820711128>3.0.CO;2-H     Document Type: Article

References (38)

1. Overview of the problem of infections in the immunocompromised host
2. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients
3. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy
4. Controversies in the management of febrile neutropenic cancer patients
5. The medical course of cancer patients with fever and neutropenia
6. β‐lactam regimens for the febrile neutropenic patient
7. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia
8. Controlled trials of double beta‐lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients
9. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients
10. Aztreonam activity, pharmacology, and clinical use
11. Aztreonam susceptibility testing
12. Aztreonam therapy in neutropenic patients with cancer
13. Immunogenicity and cross‐allergenicity of aztreonam
14. Clindamycin
15. Clindamycin treatment of experimental chronic osteomyelitis due to
16. Aztreonam plus clindamycin as therapy for pelvic infections in women
17. Quinolone resistance
18. Combination effects of ciprofloxacin, clindamycin, and metronidazole intravenously in volunteers
19. Intravenous antibiotic therapy at home
20. Home intravenous antibiotic therapy: a team approach
21. Intravenous antibiotic therapy in an outpatient setting
22. Intravenous antibiotic therapy at home
23. Home intravenous antimicrobial therapy provided by a community hospital and a university hospital
24. Outpatient intravenous antibiotic therapy
25. Savings from outpatient antibiotic therapy for osteomyelitis
26. Cost analysis of a home intravenous antibiotic program
27. Cost‐effectiveness of outpatient parenteral antibiotics: a review of the literature
28. Outpatient use of ceftriaxone: a cost‐benefit analysis
29. Prescribing antibiotics in home health care: problems and prospects
30. Origin of infection in acute non‐lymphocytic leukemia: significance of hospital acquisition of potential pathogens
31. Risk assessment in cancer patients with fever and neutropenia: a prospective, two‐center validation of a prediction rule
32. Acute renal failure due to ciprofloxacin
33. Allergic nephropathy associated with ciprofloxacin
34. Acute renal failure secondary to oral ciprofloxacin therapy: a presentation of three cases and a review of the literature
35. Oral ciprofloxacin therapy for infections in cancer patients
36. Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy
37. An improved approximate formula for calculating sample sizes for comparing two binomial distributions
38. Pneumonia caused by gram‐negative bacilli